Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Prostatectomy & nephrectomy · Texas | Prostatectomy & nephrectomy · Florida | |
|---|---|---|
| Surgeons, 2024 | 41 | 36 |
| Medicare fee-for-service cases | 2,404 | 2,306 |
| Growth since 2019 (Medicare FFS) | −0.5%/yr | +0.2%/yr |
| Forecast cases (Medicare FFS) | 3,280 in 2030 | 2,680 in 2030 |
| Forecast growth | +5.3%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.2 | 1.1 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 59 | 64 |
| Top 10 surgeons' share | 49% | 60% |
| Surgeons growing | 2 | 2 |
| New since the base year | 1 | 5 |
| Likely to stop billing it | 12 by 2026 | 8 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $16K | $21K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.